Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.
No Responses
Reading Time: < 1 minute
Liz Parrish and 2yr follow-up from telomerase gene therapy

Dr. Ed Park intervewed Liz Parrish, founder of BioViva Sciences at the the 2017 RAADFest. She discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.

Leave a Comment

Your email address will not be published. Required fields are marked *

How can I help you?

Drop me a line to find out

Contact Us

© 2020 Recharge Biomedical

Exosomes and TA-65 are not FDA-approved to prevent or treat any illness

Interested, confused, or curious?

Most questions answered in 24hrs

Fill in the form to email Dr. Park with your question